| Job alert | Jobs 1 - 6 of 6 |
Associate II Reg CMC Strategy, SI LCM
Pfizer
–
Chennai, Tamil Nadu, India
... Sterile injectable manufacturing and regulatory data requirements for submission. Knowledge on general standards, processes and policies of Pharmaceutical Industry. Work Location Assignment: Flexible Pfizer is an equal opportunity employer and ... - May 02
Associate II - Reg CMC Strategy, SI LCM
Pfizer
–
Chennai, Tamil Nadu, India
... Experience in filing Sterile Injectables submission is preferable. Preferred Attributes: Good oral and written English communication skills. Good conceptual, analytical, problem solving, and organizational skills. Well-organized and accustomed to ... - May 02
Pharmacist
Chennai Urology and Robotics Institute
–
Chennai, Tamil Nadu, India
... sterile medications, for example, intravenous medications set up and supervise clinical trials carry out teaching within the pharmacy department and in other areas of the hospital - this would only be once you have gained substantial experience. ... - Apr 26
Associate II - Reg CMC Strategy, SI LCM
myGwork - LGBTQ+ Business Community
–
Chennai, Tamil Nadu, India
... Experience in filing Sterile Injectables submission is preferable. Preferred Attributes: Good oral and written English communication skills. Good conceptual, analytical, problem solving, and organizational skills. Well-organized and accustomed to ... - May 05
Senior Executive-QC
Piramal Pharma Ltd
–
Chennai, Tamil Nadu, India
... We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug products. PPS also offers development and ... - Apr 26
Deputy Manager-EHS
Piramal Pharma Ltd
–
Chennai, Tamil Nadu, India
... We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug products. PPS also offers development and ... - Apr 29